WANY
WST icon

Wealthspire Advisors (New York)’s West Pharmaceutical WST Stock Holding History

Wealthspire Advisors (New York)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
1,402
+154
+12% +$47.1K ﹤0.01% 800
2026
Q1 		$313K Buy
+1,248
New +$311K ﹤0.01% 710
2025
Q4 		– Sell
-49
Closed -$12.9K – 2914
2025
Q3 		$12.9K Buy
+49
New +$11.9K ﹤0.01% 1893

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wealthspire Advisors (New York)'s WST Position: Q2 2026 in Review

Wealthspire Advisors (New York) increased its West Pharmaceutical (WST) stake by 12% in Q2 2026, buying an estimated $47.1K and bringing the position to 1,402 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Wealthspire Advisors (New York) first reported a position in WST in Q3 2025 and has held it in 3 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Wealthspire Advisors (New York) held 1,402 shares of West Pharmaceutical worth $503K as of Q2 2026.
  • Wealthspire Advisors (New York) bought 154 West Pharmaceutical shares in Q2 2026, an estimated $47.1K.
  • West Pharmaceutical made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #800 holding.
  • Wealthspire Advisors (New York) first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.